A systematic review of knowledge, attitude and practice of pharmacogenomics in pediatric oncology patients
Abstract Pharmacogenomics remains underutilized in clinical practice, despite the existence of internationally recognized, evidence‐based guidelines. This systematic review aims to understand enablers and barriers to pharmacogenomics implementation in pediatric oncology by assessing the knowledge, a...
Main Authors: | Claire Moore, Smaro Lazarakis, Tayla Stenta, Marliese Alexander, Rachel Phan Nguyen, David A. Elliott, Rachel Conyers |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.1150 |
Similar Items
-
Pharmacogenomics in pediatric oncology: possibility to overcome drug-induced toxicity of anticancer treatment
by: Yu. V. Dinikina, et al.
Published: (2024-01-01) -
Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology
by: Emma C. Bernsen, et al.
Published: (2020-08-01) -
Updating the landscape of direct-to-consumer pharmacogenomic testing
by: Filipski KK, et al.
Published: (2017-08-01) -
Pharmacogenomics Implementation Training Improves Self-Efficacy and Competency to Drive Adoption in Clinical Practice
by: Fadhli Adesta, et al.
Published: (2021-06-01) -
Pharmacogenomics /
by: Kalow, Werner, et al.
Published: (2005)